Redburn Partners analyst Simon Baker initiates coverage on Abbott Laboratories (NYSE:ABT) with a Neutral rating.
Redburn Partners Initiates Coverage On Abbott Laboratories with Neutral Rating
Redburn Partners analyst Simon Baker initiates coverage on Abbott Laboratories (NYSE:ABT) with a Neutral rating.